Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
14.15
-0.16 (-1.12%)
Sep 3, 2025, 4:10 PM AEST

Telix Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
207.16439.684.0179.0716.0260.13
Upgrade
Cash & Short-Term Investments
207.16439.684.0179.0716.0260.13
Upgrade
Cash Growth
161.27%423.29%6.25%393.44%-73.35%91.92%
Upgrade
Accounts Receivable
123.6386.344.1626.750.530.12
Upgrade
Other Receivables
-6.214.844.4614.6310.82
Upgrade
Receivables
123.6392.514931.2115.1610.95
Upgrade
Inventory
35.2323.6111.85.762.510.49
Upgrade
Prepaid Expenses
-6.868.471.70.880.66
Upgrade
Other Current Assets
325.895.22---
Upgrade
Total Current Assets
398.01568.45158.49117.7434.5772.23
Upgrade
Property, Plant & Equipment
74.1833.6220.7912.84.63.72
Upgrade
Long-Term Investments
4.063.778.36---
Upgrade
Goodwill
185.81663.33.752.983.26
Upgrade
Other Intangible Assets
398.36191.5371.4536.3437.5442.4
Upgrade
Long-Term Deferred Tax Assets
75.7728.9213.942.7--
Upgrade
Other Long-Term Assets
53.7646.160.40.220.150.14
Upgrade
Total Assets
1,190938.44276.73173.5679.85121.76
Upgrade
Accounts Payable
51.6942.5122.3811.428.644.48
Upgrade
Accrued Expenses
59.0947.8938.225.238.481.92
Upgrade
Short-Term Debt
----0.01-
Upgrade
Current Portion of Long-Term Debt
12.6911.750.66--0.2
Upgrade
Current Portion of Leases
8.371.540.410.440.450.39
Upgrade
Current Income Taxes Payable
51.7430.0613.064.98--
Upgrade
Current Unearned Revenue
5.37.547.893.634.512.55
Upgrade
Other Current Liabilities
109.7163.4929.9212.465.535.85
Upgrade
Total Current Liabilities
298.58204.78112.5258.1527.6215.4
Upgrade
Long-Term Debt
371.48341.495.62.25-0.07
Upgrade
Long-Term Leases
25.715.045.234.411.391.04
Upgrade
Long-Term Unearned Revenue
1.023.329.7116.7717.8421.99
Upgrade
Long-Term Deferred Tax Liabilities
39.195.81----
Upgrade
Other Long-Term Liabilities
31.6826.0641.9337.4531.3322.31
Upgrade
Total Liabilities
768.01586.8175.22119.1878.2860.8
Upgrade
Common Stock
473.11369.31304.2252.14124.22128.88
Upgrade
Retained Earnings
-150.98-131.79-179.73-185.42-126.13-71.72
Upgrade
Comprehensive Income & Other
99.81114.12-22.97-12.343.483.79
Upgrade
Shareholders' Equity
421.94351.64101.5154.381.5760.96
Upgrade
Total Liabilities & Equity
1,190938.44276.73173.5679.85121.76
Upgrade
Total Debt
418.25359.8311.897.11.851.7
Upgrade
Net Cash (Debt)
-211.179.7772.1171.9714.1858.43
Upgrade
Net Cash Growth
-10.61%0.21%407.61%-75.74%95.85%
Upgrade
Net Cash Per Share
-0.810.230.220.230.050.23
Upgrade
Filing Date Shares Outstanding
338.4329.55323.96316.71308.2280.41
Upgrade
Total Common Shares Outstanding
338.4334.73323.73316.34285.07280.41
Upgrade
Working Capital
99.43363.6745.9759.596.9556.84
Upgrade
Book Value Per Share
1.251.050.310.170.010.22
Upgrade
Tangible Book Value
-162.2394.1126.7514.29-38.9515.3
Upgrade
Tangible Book Value Per Share
-0.480.280.080.05-0.140.05
Upgrade
Land
18.5316.2414.156.681.711.9
Upgrade
Machinery
20.9611.491.71.161.340.49
Upgrade
Leasehold Improvements
3.352.021.31.050.270.18
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.